Taken together, this study shows that TEF is downregulated in BC cells and plays an important role in suppressing proliferation and tumorigenesis by deactivating AKT/FOXOs signalling and suggests a potential role of TEF as a diagnostic marker and valuable therapeutic target in BC. The gene discussed is AKT1; the disease is breast cancer.